Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older-Reference-Cited by-同舟云学术

Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older

Published:2005-01 Issue:1 Volume:29 Page:53-57
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Nabhan Chadi,Rundhaugen Lynn M.,Riley Mary B.,Rademaker Alfred,Boehlke Larry,Jatoi Mashal,Tallman Martin S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. Managing therapy in older adult patients with acute myeloid leukemia;Lowenberg;Semin. Hematol,2001

2. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study;Behringer;Ann. Hematol,2003

3. Treatment of acute myelogenous leukemia in older adults;Rowe;Leukemia,2000

4. Proceedings of the Symposium on Acute Leukemia Forum 95: Advances and Controversies in Induction Therapy and Treatment of Older Adults with AML. San Francisco, CA, USA; 10 November 1995. Leukemia 1996;10(Suppl)1:S1–48.

5. The challenge of acute myeloid leukemia in older patients;Sekeres;Curr. Opin. Oncol,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the treatment of acute myeloid leukemia: a systematic meta-analysis;Hematology;2022-02-27

3. Caution the arrhythmia association with antibody-drug conjugates: a pharmacovigilance study;Anti-Cancer Drugs;2021-09-17

4. The clinical development of antibody–drug conjugates — lessons from leukaemia;Nature Reviews Clinical Oncology;2021-03-23

5. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults;Expert Opinion on Biological Therapy;2020-10-05